Skip to main content
OpenTrials

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

1,103 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Dyskinesias trial results

Active, Not Recruiting

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

NCT00716066

Conditions
Autoimmune Disease, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +59 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Swedish Medical Center-First Hill Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG

NCT06892288

Conditions
Ataxia, Congenital disorder of glycosylation type 1A, Dyskinesias, +6 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Wearable Gait Sensors

NCT06628934

Conditions
Ataxia, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.

NCT07339514

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
View Trial Details
Active, Not Recruiting

An Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease (HD)

NCT06254482

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Novartis Investigative Site Clayton, Australia
  • Novartis Investigative Site Westmead, Australia
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Ottawa, Canada
View all 24 locations
View Trial Details
Active, Not Recruiting

The Role of Cerebellum in Speech

NCT03972202

Conditions
Articulation Disorders, Ataxia, Behavior, +19 more
Locations
  • University of California, Berkeley Berkeley, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Wisconsin--Madison Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease

NCT04120493

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona (Surgical Site Only) Tucson, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • CenExel Rocky Mountain Clinical Research Englewood, Colorado, United States
View Trial Details

Related conditions